cabergoline
Ligand Summary
An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE.
UNII: LL60K9J05T
PubChem: 54746
Guide to Pharmacology: 37
ChEMBL: CHEMBL1201087
DrugCentral: 460
LyCHI: X9Y8XT4M75UX
Target Activities
19 Activities
Items per page:
1 – 10 of 19
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|